151 related articles for article (PubMed ID: 23061898)
1. Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology--a QbD perspective.
Ghosh I; Schenck D; Bose S; Liu F; Motto M
Pharm Dev Technol; 2013; 18(3):719-29. PubMed ID: 23061898
[TBL] [Abstract][Full Text] [Related]
2. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
3. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
4. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
[TBL] [Abstract][Full Text] [Related]
5. Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE).
Nekkanti V; Marwah A; Pillai R
Drug Dev Ind Pharm; 2015 Jan; 41(1):124-30. PubMed ID: 24180259
[TBL] [Abstract][Full Text] [Related]
6. Quality by design approach to understand the process of nanosuspension preparation.
Verma S; Lan Y; Gokhale R; Burgess DJ
Int J Pharm; 2009 Jul; 377(1-2):185-98. PubMed ID: 19446617
[TBL] [Abstract][Full Text] [Related]
7. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
Ghosh I; Schenck D; Bose S; Ruegger C
Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
[TBL] [Abstract][Full Text] [Related]
9. Generation of wear during the production of drug nanosuspensions by wet media milling.
Juhnke M; Märtin D; John E
Eur J Pharm Biopharm; 2012 May; 81(1):214-22. PubMed ID: 22269938
[TBL] [Abstract][Full Text] [Related]
10. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
George M; Ghosh I
Eur J Pharm Sci; 2013 Jan; 48(1-2):142-52. PubMed ID: 23085547
[TBL] [Abstract][Full Text] [Related]
11. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
Karakucuk A; Celebi N; Teksin ZS
Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
[TBL] [Abstract][Full Text] [Related]
12. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
Kumar S; Xu X; Gokhale R; Burgess DJ
Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
[TBL] [Abstract][Full Text] [Related]
13. Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride.
Park SJ; Choo GH; Hwang SJ; Kim MS
Arch Pharm Res; 2013 May; 36(5):593-601. PubMed ID: 23446651
[TBL] [Abstract][Full Text] [Related]
14. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
Deng Z; Xu S; Li S
Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
[TBL] [Abstract][Full Text] [Related]
15. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions.
Kumar S; Burgess DJ
Int J Pharm; 2014 May; 466(1-2):223-32. PubMed ID: 24614581
[TBL] [Abstract][Full Text] [Related]
16. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
Merisko-Liversidge E; Liversidge GG
Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
[TBL] [Abstract][Full Text] [Related]
17. A new and improved method for the preparation of drug nanosuspension formulations using acoustic mixing technology.
Leung DH; Lamberto DJ; Liu L; Kwong E; Nelson T; Rhodes T; Bak A
Int J Pharm; 2014 Oct; 473(1-2):10-9. PubMed ID: 24984068
[TBL] [Abstract][Full Text] [Related]
18. Application of spray granulation for conversion of a nanosuspension into a dry powder form.
Bose S; Schenck D; Ghosh I; Hollywood A; Maulit E; Ruegger C
Eur J Pharm Sci; 2012 Aug; 47(1):35-43. PubMed ID: 22565066
[TBL] [Abstract][Full Text] [Related]
19. Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.
Siewert C; Moog R; Alex R; Kretzer P; Rothenhäusler B
Eur J Pharm Sci; 2018 Mar; 115():126-131. PubMed ID: 29278757
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
Verma S; Gokhale R; Burgess DJ
Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
